These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ergot derivatives in the prophylaxis of migraine: a multicentric study with a timed-release dihydroergotamine formulation. Martucci N; Manna V; Mattesi P; Troiani G; Manzoni GC; Lanfranchi M; Bono G; Micieli G Cephalalgia; 1983 Aug; 3 Suppl 1():151-5. PubMed ID: 6352046 [TBL] [Abstract][Full Text] [Related]
4. The management of migraine. Durward WF Scott Med J; 1985 Oct; 30(4):255-7. PubMed ID: 4095536 [No Abstract] [Full Text] [Related]
6. Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine. D'Alessandro R; Gamberini G; Lozito A; Sacquegna T Cephalalgia; 1983 Aug; 3 Suppl 1():156-8. PubMed ID: 6616598 [TBL] [Abstract][Full Text] [Related]
7. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches. Scott AK Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074 [TBL] [Abstract][Full Text] [Related]
9. Management of migraine. Drug Ther Bull; 1981 Aug; 19(18):69-71. PubMed ID: 7261908 [No Abstract] [Full Text] [Related]
10. Prophylactic treatment of migraine with propranolol. A clinical trial. Borgesen SE; Nielsen JL; Moller CE Acta Neurol Scand; 1974; 50(5):651-6. PubMed ID: 4611129 [No Abstract] [Full Text] [Related]
11. DHE retard for prophylactic therapy of migraine: efficacy and tolerability. Centonze V; Attolini E; Santoiemma L; Brucoli C; Macinagrossa G; Campanozzi F; Albano O Cephalalgia; 1983 Aug; 3 Suppl 1():179-84. PubMed ID: 6616601 [TBL] [Abstract][Full Text] [Related]
12. Drugs for migraine. Med Lett Drugs Ther; 1995 Mar; 37(943):17-20. PubMed ID: 7862023 [No Abstract] [Full Text] [Related]
13. Propranolol in the treatment of migraine. Wideroe TE; Vigander T Br Med J; 1974 Jun; 2(5921):699-701. PubMed ID: 4604977 [TBL] [Abstract][Full Text] [Related]
14. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Callaham M; Raskin N Headache; 1986 Apr; 26(4):168-71. PubMed ID: 3519528 [No Abstract] [Full Text] [Related]
15. [Pharmaco-epidemiological study on the prophylactic treatment of migraine. National inquiry on attitude to prescription practices by primary care physicians and neurologists in Franceø]. Lantéri-Minet M; Alchaar H; Besson G; Billé-Turc F; Bouillat J; Brudon F; Donnet A; Galletti P; Maitre M; Moene Y; Rambaud G; Rostini C; Valance J; Gastaut JL Rev Neurol (Paris); 2000 Dec; 156(12):1106-12. PubMed ID: 11139726 [TBL] [Abstract][Full Text] [Related]
17. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment. Dahlöf C; Maassen Van Den Brink A Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161 [TBL] [Abstract][Full Text] [Related]
18. Combined low-dose acetylsalicylic acid and dihydroergotamine in migraine prophylaxis. A double-blind, placebo-controlled crossover study. Bousser MG; Chick J; Fuseau E; Soisson T; Thevenet R Cephalalgia; 1988 Sep; 8(3):187-92. PubMed ID: 3197098 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study of indoramin versus dihydroergotamine in the preventive treatment of migraine]. Pradalier A; Dry J; Loisy B; Meininger V; Vicaut E; Mirabaud C; Levy M Therapie; 1988; 43(4):293-7. PubMed ID: 3055407 [No Abstract] [Full Text] [Related]